Difficulty: Medium
Average Score: 64%
Practice
25-hydroxyvitamin D3 (calcifediol) is less effective than 1,25-dihydroxyvitamin D3 (calcitriol) in stimulating intestinal calcium transport, so that hypercalcemia is less of a problem with calcifediol. This consideration is:
Correct answer
A
Rationale
In this scenario, the correct answer is A) TRUE. The rationale behind this is that 25-hydroxyvitamin D3 (calcifediol) is less potent in stimulating intestinal calcium transport compared to the active form, 1,25-dihydroxyvitamin D3 (calcitriol). This means that calcifediol is less likely to lead to excessive absorption of calcium from the intestines, reducing the risk of hypercalcemia.
Option B) FALSE is incorrect because the statement in the question is accurate based on the pharmacological properties of these two forms of vitamin D. Option C) All of the above and D) None of the above are also incorrect as they do not accurately reflect the specific information provided about the differences in effectiveness between calcifediol and calcitriol in stimulating intestinal calcium transport.
From an educational perspective, understanding the differences in the pharmacological actions of different forms of vitamin D is crucial in clinical practice. Healthcare professionals need to be aware of how these variations can impact patient outcomes, especially in managing conditions related to calcium metabolism and bone health. This knowledge is essential for making informed decisions regarding supplementation and treatment strategies to prevent complications such as hypercalcemia.
Option B) FALSE is incorrect because the statement in the question is accurate based on the pharmacological properties of these two forms of vitamin D. Option C) All of the above and D) None of the above are also incorrect as they do not accurately reflect the specific information provided about the differences in effectiveness between calcifediol and calcitriol in stimulating intestinal calcium transport.
From an educational perspective, understanding the differences in the pharmacological actions of different forms of vitamin D is crucial in clinical practice. Healthcare professionals need to be aware of how these variations can impact patient outcomes, especially in managing conditions related to calcium metabolism and bone health. This knowledge is essential for making informed decisions regarding supplementation and treatment strategies to prevent complications such as hypercalcemia.